Business
Agreement with Boots for COVID-19 sample kits
Agreement with Boots for COVID-19 sample kits.
About this update from Fortis Frontier Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 5404U\n MyHealthChecked PLC\n 06 April 2021\n \n \n \n \n THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n \n \n \n \n \n MyHealthChecked Plc\n \n \n \n (\"MyHealthChecked\" or the \"Company\") \n \n \n \n Agreement with Boots for COVID-19 sample collection kits\n \n \n \n \n \n \n MyHealthChecked kits to be available \n \n \n on \n \n \n www.boots.com\n \n \n and in store \n \n \n \n \n \n \n Related Party Transaction\n \n \n \n \n \n MyHealthChecked Plc\n (AIM: MHC),\n \n the consumer home-testing healthcare company, announces that it has entered into an agreement (\"Agreement\") via its subsidiary Concepta Diagnostics Limited with Boots UK Limited (\"Boots\"), the health and beauty retailer and pharmacy group, to launch the MyHealthChecked™ COVID-19 at-home nasal swab kit and PCR laboratory testing service via \n \n www.boots.com\n \n and across Boots \n stores in Great Britain.\n \n \n \n \n \n The general testing and pre-travel service will be launched online at Boots shortly and will also be available at 507 Boots stores in England, Wales and Scotland from April. \n \n \n \n \n \n The MyHealthChecked™ COVID-19 testing kit allows customers to take a nasal swab themselves at home and send samples safely and securely via the Royal Mail Tracked 24 service to be tested using established laboratory-based PCR detection methods. Testing is undertaken at the Manchester-based laboratories of MyHealthChecked and Yourgene Health plc (AIM: YGEN) and results are provided within 24-48 hours, via an online portal. \n \n \n \n \n \n The Agreement has an initial term of 12 months from 6 April 2021, with a one-month notice period for termination thereafter. Boots will act as non-exclusive agent for MHC for sales of the testing kit, and will receive a commission on all sales made under the Agreement through Boots' sales channels. \n \n \n \n \n \n The Agreement is expected to have a significant impact on the future performance of the MHC business ...